Albertazzi, P. et al (1998). The effect of dietary soy supplementation on hot flushes. Obstetrics & Gynecology, Jan; 91(1): 6-11.
Andersen, M. L. et al (2006). Effects of progesterone on sleep: a possible pharmacological treatment for sleep-breathing disorders? Curr Med Chem.; 13(29): 3575-82.
Barth, C., Villringer, A. and Sacher, J. (2015). Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Front Neurosci.; 9: 37.
Barton, D. L. et al (1998). Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. Journal of Clinical Oncology, Feb; 16(2): 495-500.
Benster, N., Carey A. and Wasworth, F. (2009). A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women. Post Reproductive Health, May; 15(2): 63-69.
Blanchette, S. et al (2006). Circulating progesterone and obesity in men. Horm Metab Res., May; 38(5): 330-5.
Cerner Multum (2018). Progesterone. drugs.com. [online] Available from: https://www.drugs.com/progesterone.html [accessed 18th June 2018].
Clinical Knowledge Summaries (2018). Acne vulgaris. NICE. [online] Available at: https://cks.nice.org.uk/acne-vulgaris [accessed 18th June 2018].
Clinical Knowledge Summaries (2018). Infertility. NICE. [online] Available at: https://cks.nice.org.uk/infertility [accessed 18th June 2018].
Clinical Knowledge Summaries (2014). Endometriosis. NICE. [online] Available at: https://cks.nice.org.uk/endometriosis [accessed 18th June 2018].
Clinical Knowledge Summaries (2014). Premenstrual syndrome. NICE. [online] Available at: https://cks.nice.org.uk/premenstrual-syndrome [accessed 18th June 2018].
Geller, S. E. et al (2009). Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trial. Menopause., Nov-Dec; 16(6): 1156–1166.
Holzer, G. et al (2005). Effects and side‐effects of 2% progesterone cream on the skin of peri‐ and postmenopausal women: results from a double‐blind, vehicle‐controlled, randomized study. British Journal of Dermatology, Aug; 153(3): 626-634.
Lei, B. et al (2014). Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia. PLoS One; 9(7): e103969.
Leonetti, H. B., Longo, S. and Anasti, J. N. (1999). Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstetrics & Gynecology, Aug; 94(2): 225-228.
Leonetti, H. B., Wilson, J. K. and Anasti, J. N. (2003). Topical progesterone cream has an antiproliferative effect on estrogen-stimulated endometrium. Fertility and Sterility, Jan; 79(1): 221-222.
Regensteiner, J. G. et al (1991). Short-term effects of estrogen and progestin on blood pressure of normotensive postmenopausal women. J Clin Pharmacol, Jun; 31(6): 543-8.
Tremollieres, F. A. et al (1992). Progesterone and promegestone stimulate human bone cell proliferation and insulin-like growth factor-2 production. Acta Endocrinol (Copenh), Apr; 126(4): 329-37.
WebMD. Who should not take Progesterone? [online] Available at: https://www.webmd.com/drugs/2/drug-8005/progesterone-micronized-oral/details/list-contraindications [accessed 18th June 2018].
Wren, B. (2009). Progesterone creams: do they work? Climacteric; 6(3): 184-187.
Young, S. L. and Lessey, B. A. (2010). Progesterone function in human endometrium: clinical perspectives. Seminars in Reproductive Medicine; 28(1): 1-16.